Menopause Completed Phase 4 Trials for Estradiol (DB00783)

Also known as: Menopausal

IndicationStatusPhase
DBCOND0025857 (Menopause)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00229450Estrogen and Perimenopausal DepressionTreatment
NCT03336437Estrogen and the Urogenital Microbiome in GSMBasic Science
NCT03921736Reversal of an Unfavorable Effect of Hydrochlorothiazide Compared to Angiotensin Converting Enzyme Inhibitor on Serum Uric Acid and Oxypurines Levels by Estrogen-progestin Therapy in Hypertensive Postmenopausal Women.Treatment
NCT02618148Hormone Estradiol Replacement Therapy Additional HerbalsHealth Services Research
NCT02516202The Vaginal Health TrialTreatment
NCT00626340Brain Imaging Study in Menopausal Women With and Without Major Depressive DisorderTreatment
NCT01705249Bleeding Profile With Continuous Hormone Replacement Therapy of Activelle® in Postmenopausal WomenTreatment
NCT00145522Study to Compare the Effect of Hormone Replacement Therapy (HRT) on Breast and Cardiovascular Metabolic Markers in Postmenopausal WomenTreatment
NCT00224094A Comparison of Patch vs. Pill Estrogen Therapy on Testosterone Levels and Thyroid Tests in Menopausal WomenTreatment
NCT00361075Midlife Cholesterol StudyPrevention
NCT00431093Trial to Compare the Effects of Tibolone (Livial®) and Continuous Combined Low-Dose Estradiol/Noresterone (Activelle®)Treatment
NCT01778985Effect of Preoperative Estrogen Treatment on Connective Tissues of the Pelvic FloorBasic Science